SMAD3 and Alzheimer disease: Mechanistically, deletion of Hrh4 in microglia, but not neurons, reversed cognitive deficits and decreased AD pathology in 8 months old APP/PS1 mice and two advanced AD mouse models, primarily through activation of the TGF‐β1/Smad3 signaling pathway.